Buprenorphine: an old dog with new tricks
- PMID: 39888833
- DOI: 10.1097/SPC.0000000000000743
Buprenorphine: an old dog with new tricks
Abstract
Purpose of review: The survival rate of patients with a cancer or palliative care diagnosis has improved over the years although pain remains a debilitating symptom that many patients still require treatment with opioids. Compared to full mu-opioid receptor agonists such as morphine and oxycodone, buprenorphine continues to remain a second- or third-line choice in this group of patients.We have reviewed the pharmacology and clinical utility of buprenorphine to stimulate debate around the first-line use of buprenorphine in the management of pain in cancer patients.
Recent findings: Buprenorphine has a pharmacological profile that is unique and unlike any other opioid. It is associated with many immediate and long-term benefits, with lower risks of adverse effects that make it an ideal first-line choice in the management of cancer pain.
Summary: Buprenorphine appears to be a promising choice of opioid for cancer patients. Studies have found that buprenorphine is a safe and effective choice for many patients, making it a suitable first-line option for the management of cancer pain.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Berman R, Davies A, Cooksley T, et al. Supportive care: an indispensable component of modern oncology. Clin Oncol (R Coll Radiol) 2020; 32:781–788.
-
- Paice JA, Portenoy R, Lacchetti C, et al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2016; 34:3325–3345.
-
- Bennett MI, Kaasa S, Barke A, et al. IASP Taskforce for the Classification of Chronic Pain. The IASP classification of chronic pain for ICD-11: chronic cancer-related pain. Pain 2019; 160:38–44.
-
- Palliative care for adults: strong opioids for pain relief. London: National Institute for Health and Care Excellence (NICE). 2016. (NICE Clinical Guidelines, No. 140.) www.nice.org.uk/guidance/cg140 . [Accessed 29 July 2024].
-
- Huynh P, Villaluz J, Bhandal H, et al. Long-term opioid therapy: the burden of adverse effects. Pain Med 2021; 22:2128–2130.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials